PPT-Training in monitoring and epidemiological assessment of mass drug administration for

Module 5 Diagnostic tests Learning objectives By the end of this module you should understand how to procure diagnostic tests collect blood prepare conduct and interpret . Module 5 Diagnostic tests. Learning objectives. By the end of this module, you should . understand how to:. procure . diagnostic tests. collect. . blood. . prepare. , . conduct. and . interpret. . Module 8 Survey sample builder. Learning objectives. Slide. . 2. By the end of this module, you should understand:. how to use the survey sample builder to:. determine the survey design. select random clusters and children or households. Module 2 Eligibility for a TAS. Learning objectives. By the end of this module, you should understand that the eligibility of an . IU. . for a . TAS is . assessed on the basis of:. epidemiological drug coverage (. Module 1 Background. Learning objectives. By the end of this module, you should . be able to answer the questions:. What is . lymphatic filariasis (LF)?. What is the . Global Programme to Eliminate Lymphatic Filariasis (GPELF)?. Module 7 Verification of elimination. Learning objectives. By the end of this module, you should . understand why you should:. Compile and . analyse. all data related to . LF. Prepare a national dossier. Module 4 Survey design. Learning objectives. By the end of this module, you should . understand how to determine:. a. survey site. the sampling strategy. the sample size. a critical cut-off. Slide. . Module 10 Field work. Learning objectives. By the end of this module, you should . understand the suggested approaches for:. field team organization. specimen collection and testing in . school-based . Module 9 Timetable, budget and administration. Learning objectives and overview. By the end of this module, you should understand the following aspects of administrative planning of . TAS:. Preparing . Winter 2016-17. Administration. Keystone Exams Assessment Coordinator Training. 2. Keystone Exams Administration Training. . Accountability. Any . questions concerning . School Performance Profile (SPP) reporting . Medication Compliance. Karla J. Walker, . PharmD. , DABCC, FACB. 1. Disclosures. Employed by . MedTox. Laboratories, a wholly owned . subsidiary of Laboratory . Corporation of America® Holdings.. 2. Module 1 Background. Learning objectives. By the end of this module, you should . be able to answer the questions:. What is . lymphatic filariasis (LF)?. What is the . Global Programme to Eliminate Lymphatic Filariasis (GPELF)?. Module 2 Eligibility for a TAS. Learning objectives. By the end of this module, you should understand that the eligibility of an . IU. . for a . TAS is . assessed on the basis of:. epidemiological drug coverage (. Module 7 Verification of elimination. Learning objectives. By the end of this module, you should . understand why you should:. Compile and . analyse. all data related to . LF. Prepare a national dossier. N-02-01-11 Page 1 of 31SELF-Illinois Department of Human ServicesDivision of Developmental DisabilitiesClient Name SS -- Medicaid ID Provider Name ID DHS Network General Instructions1For all resp